Global Nicotinamide Mononucleotide Hydride (NMNH) Market Growth 2025-2031

The global Nicotinamide Mononucleotide Hydride (NMNH) market size is predicted to grow from US$ 188 million in 2025 to US$ 294 million in 2031; it is expected to grow at a CAGR of 7.7% from 2025 to 2031.

NMNH, also known as Reduced Nicotinamide Mononucleotide or Reduced β-NMN, is a reduced form of β-NMN, a vital precursor for NAD+ (Nicotinamide Adenine Dinucleotide) biosynthesis. NAD+ is a crucial coenzyme in the human body that supports numerous cellular functions, including energy production, DNA repair, and overall metabolic health. NMNH has garnered attention for its potential in promoting healthy aging and enhancing metabolic functions.

United States market for Nicotinamide Mononucleotide Hydride (NMNH) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Nicotinamide Mononucleotide Hydride (NMNH) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Nicotinamide Mononucleotide Hydride (NMNH) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Nicotinamide Mononucleotide Hydride (NMNH) players cover Hygieia Biotech, ChromaDex Corp., EffePharm, Bontac Bio-Engineering (Shenzhen) Co., Ltd., Bicells Science Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Nicotinamide Mononucleotide Hydride (NMNH) Industry Forecast” looks at past sales and reviews total world Nicotinamide Mononucleotide Hydride (NMNH) sales in 2024, providing a comprehensive analysis by region and market sector of projected Nicotinamide Mononucleotide Hydride (NMNH) sales for 2025 through 2031. With Nicotinamide Mononucleotide Hydride (NMNH) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nicotinamide Mononucleotide Hydride (NMNH) industry.

This Insight Report provides a comprehensive analysis of the global Nicotinamide Mononucleotide Hydride (NMNH) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nicotinamide Mononucleotide Hydride (NMNH) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nicotinamide Mononucleotide Hydride (NMNH) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nicotinamide Mononucleotide Hydride (NMNH) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nicotinamide Mononucleotide Hydride (NMNH).

This report presents a comprehensive overview, market shares, and growth opportunities of Nicotinamide Mononucleotide Hydride (NMNH) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Lyophilized Powder
Crystallized Powder
Other

Segmentation by Application:
Food
Pharmaceuticals
Health Products
Personal Care

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hygieia Biotech
ChromaDex Corp.
EffePharm
Bontac Bio-Engineering (Shenzhen) Co., Ltd.
Bicells Science Ltd.
Xi'an Green Biotechnique Co.,Ltd.
InnovaSyn Biotech Inc.
Bonerge Lifescience
Hebei Zhuanglai Chemical Trading Co.,Ltd.
Xi'an Core Pure Co., Ltd
Provita Biotech Co., Ltd.
SENTIANBIO
Xi'an Haoze Biotechnology Co., Ltd.
Maintain Biotech Co.,Ltd

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nicotinamide Mononucleotide Hydride (NMNH) market?

What factors are driving Nicotinamide Mononucleotide Hydride (NMNH) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nicotinamide Mononucleotide Hydride (NMNH) market opportunities vary by end market size?

How does Nicotinamide Mononucleotide Hydride (NMNH) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.